The landscape of CRISPR/Cas9 for inborn errors of metabolism

AF Leal, N Fnu, E Benincore-Flórez… - Molecular genetics and …, 2023 - Elsevier
Since its discovery as a genome editing tool, the clustered regularly interspaced short
palindromic repeats and CRISPR-associated protein 9 (CRISPR/Cas9) system has opened …

Gene and cellular therapies for leukodystrophies

F Aerts-Kaya, NP van Til - Pharmaceutics, 2023 - mdpi.com
Leukodystrophies are a heterogenous group of inherited, degenerative encephalopathies,
that if left untreated, are often lethal at an early age. Although some of the leukodystrophies …

Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing

Y Hou, G Ureña-Bailén, T Mohammadian Gol, PG Gratz… - Genes, 2022 - mdpi.com
X-linked severe combined immunodeficiency (X-SCID) is a primary immunodeficiency that is
caused by mutations in the interleukin-2 receptor gamma (IL2RG) gene. Some patients …

Mammalian sulfatases: Biochemistry, disease manifestation, and therapy

R Mashima, M Nakanishi - International Journal of Molecular Sciences, 2022 - mdpi.com
Sulfatases are enzymes that catalyze the removal of sulfate from biological substances, an
essential process for the homeostasis of the body. They are commonly activated by the …

Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells

R Murugesan, KV Karuppusamy… - Frontiers in Genome …, 2023 - frontiersin.org
Advancements in gene delivery and editing have expanded the applications of autologous
hematopoietic stem and progenitor cells (HSPCs) for the treatment of monogenic and …

Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders

V Buffa, JR Alvarez Vargas, A Galy… - Frontiers in Genome …, 2023 - frontiersin.org
Lessons learned from decades-long practice in the transplantation of hematopoietic stem
and progenitor cells (HSPCs) to treat severe inherited disorders or cancer, have set the …

Accelerated generation of gene‐engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9

JS Antony, AM Herranz… - Biotechnology …, 2024 - Wiley Online Library
Chinese hamster ovary (CHO) cells are the commonly used mammalian host system to
manufacture recombinant proteins including monoclonal antibodies. However unfavorable …

Metachromatic leukodystrophy: To screen or not to screen?

AI Jonckheere, SDK Kingma, F Eyskens… - European Journal of …, 2023 - Elsevier
Metachromatic leukodystrophy (MLD) is a neurodegenerative lysosomal storage disorder
caused by biallelic pathogenic variants in the gene encoding arylsulfatase A. Disease onset …

Identification of a Novel ARSA Gene Mutation Through High-Throughput Molecular Diagnosis Method in Two Girls with Late Infantile Metachromatic Leukodystrophy

A Yari, F Vafaeie, ZM Karam, M Hosseini… - Neuromolecular …, 2023 - Springer
Metachromatic leukodystrophy (MLD) is a rare leukoencephalopathy caused by pathogenic
mutations in the ARSA gene. It manifests as severe motor symptoms, mental problems, and …

Challenges with gene therapy based on CRISPR/Cas9 and prime editing for somatic reverted mosaicism of X-linked combined immunodeficiency

Y Hou - 2024 - ub01.uni-tuebingen.de
X-linked severe combined immunodeficiency (X-SCID) is a rare primary immunodeficiency
disorder with X-chromosome-linked recessive inheritance, that is caused by the mutations of …